Norfloxacin In Dental Practice

Authors

  • Christopher Joel Simon Department of Prosthodontics, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai,India Author
  • Anitha Roy Associate professor, Department of Physiology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai,India Author
  • Revathy Duraisawamy Senior Lecturer, Department of Prosthodontics, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai,India Author
  • Dhanraj Ganapathy Professor and Head Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical And Technical Sciences, Chennai – 600077 Tamil Nadu, India Author

DOI:

https://doi.org/10.61841/0ckp6p97

Keywords:

dental practice, odontogenic infections, Periodontal disease, dental caries, gingivitis, periodontits, norfloxacin

Abstract

Antibiotics are commonly used in dental practice. It has been estimated that 10% of all antibiotic prescriptions are related with dental infections.Periodontal disease is caused by bacteria in dental plaque, the sticky substance that forms on your teeth a couple of hours after you have brushed. Interestingly, it is your body's response to the bacterial infection that causes most of the problems. In an effort to eliminate the bacteria, the cells of your immune system release substances that cause inflammation and destruction of the gums, periodontal ligament or alveolar bone. This leads to swollen, bleeding gums, signs of gingivitis the earliest stage of periodontal disease, and loosening of the teeth, a sign of severe periodontitis the advanced stage of disease. A Method for treating or preventing periodontal disease which comprises administering nor floxacin or salts thereof locally to periodontal tissue are disclosed. The method is excellent on the treatment of periodontal disease in small dose without disturbance of bacterial flora. The rate of progression of periodontal disease in an individual is dependent on the virulence (or strength of attack) of the bacterial plaque and on the efficiency of the local and systemic immune inflammatory responses in the person (host). The overall balance between the bacterial plaque challenge and the body’s immune inflammatory responses is critical to periodontal health. The best clinical outcome for a periodontal patient following treatment would be the retention of formerly diseased teeth for a lifetime. The vast majority of gum diseases can be easily prevented by daily thorough plaque removal. However, irregularities around the teeth such as overhanging edges on fillings, poorly contoured fillings, and some types of partial denture designs make tooth cleaning difficult and encourage the accumulation of plaque. The presence of calculus (tartar) – plaque that has calcified and hardened – may also cause plaque to accumulate more readily and requires professional removal (scaling). For the majority of the population, however, periodontal health can be effectively maintained by proper oral hygiene practices as well as avoidance of behavioral and environmental risk factors (e.g., tobacco smoke, stress, poor diet) on the part of the individual. Because periodontal disease is linked to an increased susceptibility to systemic disease (e.g., cardiovascular disease, infective endocarditis, bacterial pneumonia, low birth weight, diabetes), it is important not only for oral health but also for general health to control periodontal disease.

Downloads

Download data is not yet available.

References

1. Krayer JW, Leite RS, Kirkwood KL. Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases. Dental Clinics. 2010 Jan 1;54(1):13-33.

2. Ellen RP, McCulloch CA. Evidence versus empiricism: rational use of systemic antimicrobial agents for treatment of periodontitis. Periodontology 2000. 1996 Feb;10(1):29-44.

3. Slots J. Periodontology: past, present, perspectives. Periodontology 2000. 2013 Jun;62(1):7-19.

4. Rams TE, Slots J. Local delivery of antimicrobial agents in the periodontal pocket. Periodontology 2000. 1996 Feb;10(1):139-59.

5. Carranza FA, Camargo PM. The periodontal pocket. Clinical Periodontology, 10th ed. Philadelphia: Saunders/Elsevier. 2006:434-51.

6. Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of Clinical Periodontology. 2002 Dec;29:136-59.

7. Slots J, Smith MacDonald E, Nowzari H. Infectious aspects of periodontal regeneration. Periodontol 2000. 1999;13:64-72.

8. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Annals of Periodontology. 2003 Dec 1;8(1):115-81.

9. Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dental Research Journal. 2012 Sep;9(5):505.

10. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontology 2000. 1994 Jun;5(1):142-68.

11. Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontology 2000. 1996 Feb;10(1):45-78.

12. Golub LM, Ramamurthy NS, McNamara TF, Gomes B, Wolff M, Casino A, Kapoor A, Zambon J, Ciancio S, Schneir M, Perry H. Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease. Journal of Periodontal Research. 1984 Nov;19(6):651-5.

13. Lantz MS, Ray T, Krishnasami S, Pearson DE. Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius. Antimicrobial Agents and Chemotherapy. 1987 Dec 1;31(12):1915-8.

14. Wikesjö UM, Baker PJ, Christlrsson LA, Genco RJ, Lyall RM, Hic S, Diflorio RM, Terranova VP. A biochemical approach to periodontal regeneration: Tetracycline treatment conditions dentin surfaces. Journal of Periodontal Research. 1986 Jul;21(4):322-9.

15. Walker CB. Selected antimicrobial agents: mechanisms of action, side effects and drug interactions. Periodontology 2000. 1996 Feb;10(1):12-28.

16. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. Journal of Clinical Periodontology. 2007 Mar;34(3):243-53.

17. Gordon J, Walker C, Lamster I, West T, Socransky S, Seiger M, Fasciano R. Efficacy of clindamycin hydrochloride in refractory periodontitis: 12-month results. Journal of Periodontology. 1985 Nov;56(11s):75-80.

18. Walker CB, Gordon JM, Magnussen I, Clark WB. A role for antibiotics in the treatment of refractory periodontitis. Journal of Periodontology. 1993 Aug;64(8s):772-81.

19. Wilson M. Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections. Photochemical & Photobiological Sciences. 2004;3(5):412-8.

20. van Winkelhoff AJ, Winkel EG. Antibiotics in periodontics: right or wrong? Journal of Periodontology. 2009 Oct;80(10):1555-8.

21. Heimdahl A, Nord CE. Treatment of orofacial infections of odontogenic origin. Scand J Infect Dis. 1985;46(Suppl):101-105.

22. Baker KA, Fotos PG. The management of odontogenic infections. A rationale for appropriate chemotherapy. Dental Clinics of North America. 1994;38:689-706.

23. Morse SS. Factors in the emergence of infectious diseases. Emerging Infectious Diseases. 1995;1:7-15.

24. Judd PL, Sandor GKB. Management of odontogenic orofacial infection in the young child. Ont Dent. 1997;74:39-45.

25. Sands T, Pynn BR, Katsikeris N. Odontogenic infections: Microbiology, antibiotics, and management. Oral Health. 1995;85:11-28.

Downloads

Published

16.12.2019

How to Cite

Joel Simon, C., Roy, A., Duraisawamy, R., & Ganapathy, D. (2019). Norfloxacin In Dental Practice. International Journal of Psychosocial Rehabilitation, 23(6), 1456-1466. https://doi.org/10.61841/0ckp6p97